Disassembly of embryonic keratin filaments promotes pancreatic cancer
R. R. Kawalerski, M. Torrente Goncalves, C.-H. Pan, R. Tseng, L. Roa-Pena, C. V. Leiton, L. A. Torre-Healy, T. Boyle, S. Chowdhury, N. T. Snider, K. R. Shroyer, L. F. Escobar-Hoyos
Abstract
Keratin 17 (K17), an oncofetal intermediate filament protein, is one of the most abundantly expressed proteins in pancreatic ductal adenocarcinomas (PDACs) of the most aggressive molecular subtype. The mechanistic roles of this protein in malignancy, however, are largely unexplored. Here we show that K17 expression and disassembly enhances tumor growth and metastatic potential and shortens survival. Using mass spectrometry in K17 isolated from patients tumors, we identified a hotspot phosphorylation site in serines 10-13. Site-mutagenesis revealed that phosphorylation of this hotspot is sufficient to disassemble K17 and promote its nuclear translocation. In silico and pharmacologic inhibition studies uncovered the role of the PKC/MEK/RSK pathway in the phosphorylation and disassembly of K17. Murine models bearing tumors expressing phosphomimetic mutations at the serine hotspot displayed enhanced metastases, compared to mice bearing tumors expressing wild-type K17 or phosphorylation-resistant K17. Lastly, we found that detergent-soluble nuclear K17 promotes the expression of metastasis promoting genes in both patient and murine tumors. These results suggest that phosphorylation at specific serines is sufficient to promote pancreatic cancer metastasis and shorter survival, and that these sites could provide novel, druggable therapeutic domains to enhance PDAC patient survival.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Keratin 17 Defines an Epithelial-Mesenchymal Transition-Associated Migratory Cell State in Pancreatic Ductal Adenocarcinoma
Shayan Sarkar, Monisankar Ghosh, … Kenneth R. Shroyer·bioRxiv·Oct 29, 2026
- Identification of Phosphotyrosine-Mutant Desmin in Human Pancreatic Cancer
Nancy C. Kendrick, Costel C. Darie, … Jon J. Johansen·bioRxiv·Oct 14, 2024
- An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
C.-H. Pan, Y. Otsuka, … K. R. Shroyer·bioRxiv·Oct 11, 2019
- Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells
Philip Moresco, Jonathan P. Kastan, … Douglas T. Fearon·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 1, 2025
- Frizzled 6 Drives EMT and Stromal Remodeling Downstream of SP1 in Basal-like Pancreatic Cancer
Payton D. Stevens, Catriona S. Giannotta, … Bart O. Williams·bioRxiv·Jan 1, 2026
- Targeting keratin 17-mediated reprogramming of de novo pyrimidine biosynthesis to overcome chemoresistance in pancreatic cancer
C.-H. Pan, N. Chaika, … L. F. Escobar-Hoyos·bioRxiv·Aug 24, 2022